P

Inventor

HAN WEN-CHING

US27 patents
⚠️ This page may combine multiple inventors who share the name “HAN WEN-CHING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

24 patents
US6262096B1Jul 17, 2001

Aminothiazole inhibitors of cyclin dependent kinases

BRISTOL MYERS SQUIBB CO81 citations96
US6040321AMar 21, 2000

Aminothiazole inhibitors of cyclin dependent kinases

BRISTOL MYERS SQUIBB CO85 citations96
US5583146ADec 10, 1996

Heterocyclic thrombin inhibitors

BRISTOL MYERS SQUIBB CO65 citations96
US5741792AApr 21, 1998

Heterocyclic thrombin inhibitors

BRISTOL MYERS SQUIBB CO27 citations92
US5561146AOct 1, 1996

Modified guanidino and amidino thrombin inhibitors

BRISTOL MYERS SQUIBB CO49 citations92
US7151176B2Dec 19, 2006

Pyrrolotriazine compounds

BRISTOL MYERS SQUIBB CO12 citations84
US5741799AApr 21, 1998

Heterocyclic thrombin inhibitors

BRISTOL MYERS SQUIBB CO15 citations81
US7297695B2Nov 20, 2007

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO9 citations74
US7141571B2Nov 28, 2006

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO8 citations74
US7064203B2Jun 20, 2006

Di-substituted pyrrolotriazine compounds

BRISTOL MYERS SQUIBB CO9 citations74
US9492460B2Nov 15, 2016

Carbazole compounds useful as bromodomain inhibitors

BRISTOL MYERS SQUIBB CO4 citations73
US6521759B2Feb 18, 2003

Aminothiazole inhibitors of cyclin dependent kinases

BRISTOL MYERS SQUIBB CO6 citations73
US9725449B2Aug 8, 2017

Tricyclic compounds as anticancer agents

BRISTOL MYERS SQUIBB CO2 citations71
US9273075B2Mar 1, 2016

Prodrugs of 1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO4 citations70
US7846931B2Dec 7, 2010

Pyrrolotriazine compounds as kinase inhibitors

BRISTOL MYERS SQUIBB CO1 citations63
US7417040B2Aug 26, 2008

Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

BRISTOL MYERS SQUIBB CO3 citations63
US7378426B2May 27, 2008

Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

BRISTOL MYERS SQUIBB CO2 citations63
US9133139B2Sep 15, 2015

Fluoroalkyl-1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO2 citations62
US9427442B2Aug 30, 2016

Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO0 citations52
US9751879B2Sep 5, 2017

Tricyclic compounds as anticancer agents

BRISTOL MYERS SQUIBB CO1 citations51
US9242940B2Jan 26, 2016

N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO0 citations51
US9242941B2Jan 26, 2016

Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO0 citations41
US10174024B2Jan 8, 2019

5H-pyrido[3,2-B]indole compounds as anticancer agents

BRISTOL MYERS SQUIBB CO0 citations40
US7468439B2Dec 23, 2008

Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO0 citations40

SQUIBB & SONS INC

2 patents

NORRIS DEREK J

1 patent